219 related articles for article (PubMed ID: 31520213)
1. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
[TBL] [Abstract][Full Text] [Related]
2. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis.
Peacock O; Smith N; Waters PS; Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
Colorectal Dis; 2020 Jul; 22(7):818-823. PubMed ID: 31961476
[TBL] [Abstract][Full Text] [Related]
4. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
[TBL] [Abstract][Full Text] [Related]
5. ASO Author Reflections: Major Morbidity After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies.
Peacock O; Waters PS; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):415-416. PubMed ID: 31686345
[No Abstract] [Full Text] [Related]
6. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
7. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
8. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.
Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M
Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
11. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
[TBL] [Abstract][Full Text] [Related]
12. [Observational study on perioperative outcomes of pelvic exenteration].
Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126
[No Abstract] [Full Text] [Related]
13. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
[TBL] [Abstract][Full Text] [Related]
14. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
15. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
[TBL] [Abstract][Full Text] [Related]
17. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
19. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
20. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]